Literature DB >> 21514759

Development of hepatocellular carcinomas in patients with absence of tumors on a prior ultrasound examination.

Kyung Ah Kim1, Myeong-Jin Kim, Jin-Young Choi, Yong Eun Chung.   

Abstract

BACKGROUND: To evaluate hepatocellular carcinoma (HCC) that developed in patients with no evidence of a tumor during a prior ultrasound (US) performed within 1 year of the diagnosis.
METHODS: We retrospectively analyzed data for 100 consecutive patients with liver cirrhosis who had undergone US within 1 year prior to HCC diagnosis and who showed no liver lesions on the previous US. Size and T stage of HCC were assessed as well as whether patients met surgical criteria for liver transplantation as HCC treatment [Milan or University of California at San Francisco (UCSF) criteria].
RESULTS: The mean interval between the negative and diagnostic scans was 5 months, 13 days. HCC presented as a single nodule in 69 patients (size, 0.8-8.0 cm), as two or more nodules in 18 patients, and as the diffuse form of HCC in 13 patients. HCC presented as a small tumor (<3 cm) in 48 patients. T stages were: T1 in 26 patients, T2 in 45, T3 in 18, and T4 in 11. The Milan criteria were met in 79 patients. Eighty-five patients fulfilled the UCSF.
CONCLUSION: Patients may present with advanced HCC, even if sonographic findings were negative within 1 year prior to diagnosis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21514759     DOI: 10.1016/j.ejrad.2011.03.053

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

Review 1.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Authors:  Alexander Kagen; Kathryn Fowler; Claude B Sirlin
Journal:  Hepat Oncol       Date:  2013-12-20

Review 3.  Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.

Authors:  Sonal Krishan; Radha K Dhiman; Navin Kalra; Raju Sharma; Sanjay S Baijal; Anil Arora; Ajay Gulati; Anu Eapan; Ashish Verma; Shyam Keshava; Amar Mukund; S Deva; Ravi Chaudhary; Karthick Ganesan; Sunil Taneja; Ujjwal Gorsi; Shivanand Gamanagatti; Kumble S Madhusudan; Pankaj Puri; Shallini Govil; Manav Wadhavan; Sanjiv Saigal; Ashish Kumar; Shallini Thapar; Ajay Duseja; Neeraj Saraf; Anubhav Khandelwal; Sumit Mukhopadyay; Ajay Gulati; Nitin Shetty; Nipun Verma
Journal:  J Clin Exp Hepatol       Date:  2019-08-06

Review 4.  MRI of hepatocellular carcinoma: an update of current practices.

Authors:  Hina Arif-Tiwari; Bobby Kalb; Surya Chundru; Puneet Sharma; James Costello; Rainner W Guessner; Diego R Martin
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

5.  MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.

Authors:  Seungsoo Lee; Kyung Ah Kim; Mi-Suk Park; Sun Young Choi
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

6.  Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.

Authors:  Hyun A Kim; Kyung Ah Kim; Joon-Il Choi; Jeong Min Lee; Chang Hee Lee; Tae Wook Kang; Young-Mi Ku; Su Lim Lee; Yang Shin Park; Jeong Hee Yoon; Seong Hyun Kim; Moon Hyung Choi
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

7.  Advanced-stage hepatocellular carcinoma presenting without radiographic liver lesions.

Authors:  Charles Mupamombe; Rajesh Veluvolu; Arslan Ahmad; Mohan Preet; Evelyn Taiwo
Journal:  Clin Case Rep       Date:  2018-04-06

8.  Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.

Authors:  Chansik An; Do Young Kim; Jin-Young Choi; Kwang Hyub Han; Yun Ho Roh; Myeong-Jin Kim
Journal:  BMC Cancer       Date:  2018-09-24       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.